WILMINGTON, N.C., Feb. 15, 2008 (PRIME NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release fourth quarter and full year 2007 financial results after market close on Thursday, February 21st, 2008. Rick Randall, President and Chief Executive Officer of TranS1, and Mike Luetkemeyer, Chief Financial Officer, will host a conference call starting at 4:30 pm EST on the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial 800-437-3848 for domestic callers and 719-785-1768 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the TranS1 Web site at http://www.trans1.com under the investor relations section.
Schedule this webcast into MS-Outlook calendar (click open when prompted):http://apps.shareholder.com/PNWOutlook/t.aspx?m=29862&k=3444F46B
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products -- the AxiaLIF(r) and the AxiaLIF 360:o(tm) in the U.S. and Europe. In addition the company currently markets a two-level fusion product -- the AxiaLIF 2L(tm) in Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit http://www.trans1.com.